Rome
Italy
30
2020-10-15
The entities that hold a legal rights for patent applications filed by inventor Koverech Aleardo:
Aleardo Koverech from Rome, IT has applied for patents for these inventions. The list has both pending applications and granted patents:
Compounds useful for increasing neurogenesis in neural tissue
#2 | 2016-10-27COMPOUNDS USEFUL FOR INCREASING NEUROGENESIS IN NEURAL TISSUE
#3 | 2014-10-30COMPOUND USEFUL FOR TREATING CELLULITE
#4 | 2014-10-02COMPOUND WITH ANTIBACTERIAL ACTIVITY
#5 | 2014-10-02COMPOSITION FOR TIPICAL USE FOR TREATING SKIN DISORDERS
#6 | 2014-03-27Composition useful for the treatment of lipid metabolism disorders
#7 | 2014-03-20COMPOUNDS USEFUL FOR THE PREVENTION OR TREATMENT OF ACCOMMODATIVE ASTHENOPIA
#8 | 2014-02-20Therapeutical method for the treatment of the Leber optic neuropathy
#9 | 2014-01-16Combination composition, comprising as active ingredients L-carnitine or propionyl L-carnitine, for the prevention or treatment of chronic venous insufficiency
#10 | 2013-08-08COMPOUNDS USEFUL FOR INCREASING NEUROGENESIS IN NEURAL TISSUE
#11 | 2013-05-30GEL USEFUL FOR THE DELIVERY OF OPHTHALMIC DRUGS
#12 | 2013-02-21COMPOSITION COMPRISING AS ACTIVE INGREDIENT L-CARNITINE IN COMBINATION WITH A SOLAR FILTER, FOR THE PREVENTION AND/OR TREATMENT OF PATHOLOGIES OF THE EYE DUE TO ULTRAVIOLET RADIATION
#13 | 2013-01-03COMBINATION COMPOSITION, COMPRISING AS ACTIVE INGREDIENTS L-CARNITlNE OR PROPIONYL L-CARNITlNE, FOR THE PREVENTION OR TREATMENT OF CHRONIC VENOUS INSUFFICIENCY
#14 | 2011-11-03COMPOUNDS USEFUL FOR THE PREVENTION OR TREATMENT OF ACCOMODATIVE ASTHENOPIA
#15 | 2011-09-08COMPOUND USEFUL FOR TREATING CELLULITE
#16 | 2011-08-04Combination composition, comprising as active ingredients L-carnitine or propionyl L-carnitine, for the prevention or treatment of chronic venous insufficiency
#17 | 2011-04-14Use of L-carnitine for the treatment of cardiovascular diseases
#18 | 2010-04-15Use of L-carnitine or of alkanoyl L-carnitines for the preparation of a physiological supplement or medicament for ophthalmic use in the form of eye drops
#19 | 2010-03-18Gel useful for the delivery of ophthalmic drugs
#20 | 2010-03-18Use of L-carnitine for the preparation of a medicament in the form of eye-drops for treating corneal diseases
#21 | 2009-03-19Use of acetyl L-carnitine for the treatment of fibromyalgic syndrome
#22 | 2009-02-12Use of L-carnitine for the treatment of cardiovascular diseases
#23 | 2009-01-08Combined use of L-carnitine, acetyle L-carnitine and propionyl L-carnitine for the treatment of oligoasthenoteratospermia
#24 | 2008-11-20Carnitines for treating or preventing disorders caused by andropause
#25 | 2008-04-17Use of acetyl L-carnitine in combination with propionyl L-carnitine and Sildenafil for the treatment of erectile dysfunction
#26 | 2007-11-15Use of L-carnitine or of alkanoyl L-carnitines for the preparation of a physiological supplement or medicament for opthalmic use in the form of eye drops
#27 | 2007-09-06Use of L-carnitine for the treatment of cardiovascular diseases
#28 | 2006-06-22Use of carnitines for the prevention and/or treatment of disorders caused by the andropause
#29 | 2005-06-30Administration of isovaleryl L-carnitine to stimulate osteoblastic activity
#30 | 2005-06-14Use of isovaleryl L-carnitine to increase healing of bone fractures
13682 ⎘